[ad_1]
CONMED Co. (NYSE:CNMD – Get Ranking) VP Stanley W. Peters III offered 7,500 shares of the enterprise’s inventory in a transaction dated Friday, August 12th. The inventory was offered at a median worth of $100.90, for a complete transaction of $756,750.00. Following the sale, the vice chairman now immediately owns 63 shares within the firm, valued at $6,356.70. The sale was disclosed in a authorized submitting with the SEC, which is obtainable by way of this hyperlink.
CONMED Inventory Efficiency
CNMD traded up $0.06 on Monday, reaching $103.21. The corporate had a buying and selling quantity of 239,056 shares, in comparison with its common quantity of 367,621. CONMED Co. has a fifty-two week low of $87.24 and a fifty-two week excessive of $159.11. The inventory has a market cap of $3.14 billion, a P/E ratio of 53.20, a P/E/G ratio of three.19 and a beta of 1.53. The corporate’s fifty day shifting common is $98.85 and its 200 day shifting common is $102.14. The corporate has a debt-to-equity ratio of 0.86, a fast ratio of 1.16 and a present ratio of two.34.
CONMED (NYSE:CNMD – Get Ranking) final introduced its quarterly earnings outcomes on Wednesday, July 27th. The corporate reported $0.76 EPS for the quarter, assembly analysts’ consensus estimates of $0.76. CONMED had a internet margin of 6.19% and a return on fairness of 13.20%. The enterprise had income of $277.19 million for the quarter, in comparison with analyst estimates of $273.78 million. As a bunch, analysts predict that CONMED Co. will submit 3.7 earnings per share for the present fiscal yr.
CONMED Dividend Announcement
The agency additionally just lately introduced a quarterly dividend, which can be paid on Wednesday, October fifth. Shareholders of file on Thursday, September 15th can be given a dividend of $0.20 per share. The ex-dividend date is Wednesday, September 14th. This represents a $0.80 dividend on an annualized foundation and a dividend yield of 0.78%. CONMED’s payout ratio is presently 41.24%.
Institutional Inflows and Outflows
Institutional buyers and hedge funds have just lately made modifications to their positions within the enterprise. Parkside Monetary Financial institution & Belief grew its place in shares of CONMED by 113.2% in the course of the 4th quarter. Parkside Monetary Financial institution & Belief now owns 194 shares of the corporate’s inventory value $28,000 after buying an extra 103 shares within the final quarter. Confluence Wealth Companies Inc. acquired a brand new place in shares of CONMED in the course of the 4th quarter value roughly $32,000. Fifth Third Bancorp grew its place in shares of CONMED by 42.4% in the course of the 4th quarter. Fifth Third Bancorp now owns 252 shares of the corporate’s inventory value $36,000 after buying an extra 75 shares within the final quarter. CWM LLC grew its place in shares of CONMED by 258.7% in the course of the 2nd quarter. CWM LLC now owns 513 shares of the corporate’s inventory value $49,000 after buying an extra 370 shares within the final quarter. Lastly, FinTrust Capital Advisors LLC lifted its holdings in shares of CONMED by 33.6% in the course of the 2nd quarter. FinTrust Capital Advisors LLC now owns 1,550 shares of the corporate’s inventory value $158,000 after buying an extra 390 shares in the course of the interval.
Analysts Set New Value Targets
A number of equities analysis analysts have commented on the inventory. StockNews.com raised shares of CONMED from a “promote” ranking to a “maintain” ranking in a analysis report on Tuesday, August ninth. Stifel Nicolaus lowered their worth goal on shares of CONMED from $160.00 to $110.00 and set a “purchase” ranking on the inventory in a analysis notice on Thursday, June 23rd. TheStreet lowered shares of CONMED from a “b-” ranking to a “c+” ranking in a analysis notice on Tuesday, June 21st. Needham & Firm LLC lowered their worth goal on shares of CONMED from $155.00 to $127.00 and set a “purchase” ranking on the inventory in a analysis notice on Thursday, July 28th. Lastly, Piper Sandler lowered their worth goal on shares of CONMED from $160.00 to $118.00 and set an “obese” ranking on the inventory in a analysis notice on Thursday, July 28th. Two analysts have rated the inventory with a maintain ranking and three have given a purchase ranking to the inventory. In response to MarketBeat.com, the corporate presently has a consensus ranking of “Average Purchase” and a median goal worth of $118.33.
CONMED Firm Profile
CONMED Company, a medical know-how firm, develops, manufactures, and sells surgical gadgets and associated gear for surgical procedures worldwide. It gives orthopedic surgical procedure merchandise, together with TruShot with Y-Knot All-In-One Tender Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which offer distinctive medical options to orthopedic surgeons for the restore of sentimental tissue accidents, in addition to supporting merchandise that allow surgeons to carry out minimally invasive sports activities medication surgical procedures.
Advisable Tales
This on the spot information alert was generated by narrative science know-how and monetary information from MarketBeat in an effort to present readers with the quickest and most correct reporting. This story was reviewed by MarketBeat’s editorial workforce previous to publication. Please ship any questions or feedback about this story to contact@marketbeat.com.
Earlier than you think about CONMED, you may need to hear this.
MarketBeat retains observe of Wall Avenue’s top-rated and greatest performing analysis analysts and the shares they suggest to their shoppers every day. MarketBeat has recognized the 5 shares that high analysts are quietly whispering to their shoppers to purchase now earlier than the broader market catches on… and CONMED wasn’t on the checklist.
Whereas CONMED at the moment has a “Average Purchase” ranking amongst analysts, top-rated analysts consider these 5 shares are higher buys.
[ad_2]
Supply hyperlink